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Sunday, March 1, 2009 115aThe time- and calcium-dependent association of recombinant human copine I
or annexin A1 with supported lipid bilayers composed of 25% brain PS and
75% DOPC was monitored by atomic force microscopy. Neither protein bound
to featureless areas of the bilayer but both rapidly bound to small domains that
appeared to be 0.5 to 0.8 nm lower than the rest of the bilayer. These domains
may be enriched in PS and/or have a more disordered lipid structure. Copine I
assembled into a reticular pattern made of 40nm linear elements that appeared
to be one or two molecules high. In vivo such copine arrays might form a scaf-
fold for the assembly of signalling proteins bound by copine I. Annexin A1 did
not form ordered structures but appeared to promote the growth of the domains
of lowered height to which it was bound. These enlarged domains created by
annexin A1 provided binding sites for copine I when it was added subsequently.
Therefore, in vivo, annexin A1 might recruit C2 domain-containing proteins
like copine to membranes by modulating membrane structure.
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In HEK cells stably expressing receptors for type 1 parathyroid hormone
(PTH), PTH increases the sensitivity of IP3 receptors (IP3R) to IP3 via
a cAMP-dependent mechanism, thereby potentiating Ca2þ signals evoked by
muscarinic M3 receptors that stimulate IP3 formation. The effect of PTH results
from cAMP binding directly to a low-affinity site on either the IP3R itself or
a protein tightly associated with it. cAMP appears to pass directly from AC
to IP3R via an association we have termed an AC-IP3R junction, formed selec-
tively by AC6 and IP3R2. Here we show disruption of cholesterol-rich lipid mi-
crodomains differentially disrupts M3R signaling in HEK cells.
In the absence of extracellular Ca2þ, stimulation of HEK cells with a maximal
concentration of carbachol (CCh, 1mM) caused an increase in [Ca2þ]i of 2495
33nM which returned to basal within 60–70s. Subsequent addition of PTH, in
the continued presence of CCh, evoked further concentration-dependent (EC50
¼ 595 15nM) increases in [Ca2þ]i. Treatment with the cholesterol-depleting
agent MbCD (2h; 22C) caused an 865 3% decrease in the response to CCh
whilst having no significant effect on the response to PTH. Single-cell imaging
revealed that treatment with MbCD caused a 30% decrease in the number of
cells responding to CCh and a 45% decrease in amplitude of the Ca2þ signal
in cells that did respond. Filipin staining of free cholesterol confirmed that
MbCD caused depletion of cellular cholesterol.
Depletion of intracellular cholesterol with MbCD disrupts CCh but not PTH
signalling in HEK293 cells. We hypothesise this may be due to the existence
of either two different M3R populations in the PM or differential distributions
of IP3R isoforms in the ER.
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Malignant hyperthermia (MH) is a life-threatening syndrome triggered by vol-
atile anesthetics, in which uncontrolled elevation of myoplasmic Ca2þ leads to
hypercontracture of skeletal muscle and elevation of body temperature. Our re-
cent study showed that azumolene, an analog of dantrolene used to treat MH,
inhibits a component of store-operated Ca2þ entry (SOCE) coupled to activa-
tion of the ryanodine receptor in skeletal muscle (JBC 281: 33477, 2006).
Given our previous observation that overexpression of calsequestrin-1
(CSQ1) suppressed SOCE in skeletal muscle (JBC 278: 3286, 2003), here
we tested the hypothesis that reduced CSQ1 expression would enhance an azu-
molene-sensitive SOCE in this tissue. A shRNA probe specific for CSQ1 (JBC
281: 15772, 2006) was introduced into flexor digitorum brevis (FDB) muscles
of living mice using electroporation. Individual transfected FDB muscle fibers
labeled with a fluorescent marker were isolated for SOCE measurements using
Mn-quenching of Fura-2 fluorescence. At room temperature (20–22C), SOCE
induced by caffeine/ryanodine was significantly enhanced in CSQ1-knock-
down muscle fibers (in 104 DF360/s, 9.36 5 1.31) compared to those trans-
fected with control (4.71 5 1.29, p<0.05). Pre-incubation with azumolene
(20 mM) completely inhibited the elevated SOCE detected in CSQ1-knock-
down fibers (1.26 5 0.38, p<0.01). To prevent muscle contraction, we used
N-benzyl-p-toluene sulfonamide (BTS, 40 mM), a specific myosin II inhibitor.
When temperature of the bathing solution was increased to 40C, muscle fiberswith knockdown of CSQ1 displayed a significant elevation in cytosolic Ca2þ
over that seen in control fibers. Thus reduced CSQ1 expression is likely cou-
pled to elevation of cytosolic Ca2þ due to increased SOCE function at higher
temperatures. These results suggest that elevated SOCE activity in skeletal
muscle may be linked to the pathophysiology of MH and the heat-sensitivity
of MH-susceptible animals.
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To explore the role of protein kinase A (PKA) phosphorylation of the cardiac
ryanodine receptor (RyR2)/calcium release channel in the treatment of heart
failure (HF) using beta-adrenergic receptor blockers (beta-blockers) we gener-
ated a knock-in mouse with aspartic acid replacing serine at residue 2808 in
RyR2 (RyR2-S2808D). This mutation mimics constitutive PKA hyperphos-
phorylation of RyR2, a condition that occurs during HF. RyR2-S2808Dþ/þ
mice developed an age-dependent cardiomyopathy characterized by moderate
cardiac dysfunction and mild left ventricular dilatation indicating that PKA hy-
perphosphorylation of RyR2 alone can cause cardiac dysfunction. Following
myocardial infarction (MI), RyR2-S2808Dþ/þ mice exhibited increased mor-
tality compared to WT littermates. Treatment with the rycal S107, a 1,4-benzo-
thiazepine derivative that inhibits PKA hyperphosphorylation-induced deple-
tion of calstabin2 from the RyR2 complex, for 4 weeks significantly reduced
HF progression in WT and RyR2-S2808Dþ/þ mice, confirming the important
role of calstabin2 binding to RyR2 in preventing HF progression. In contrast,
following MI, treatment with the beta-adrenergic receptor blocker (beta-
blocker) metoprolol improved cardiac function in WT but not in RyR2-
S2808Dþ/þ mice, indicating the important role of inhibition of PKA hyper-
phosphorylation of RyR2 as a key mechanism underlying the beneficial effects
of beta-blockers in HF. Taken together, these data show that chronic RyR2
PKA hyperphosphorylation alone can cause a cardiomyopathy, preventing cal-
stabin2 depletion from the RyR2 macromolecular complex can inhibit HF pro-
gression, and PKA phosphorylation of RyR2 is an important determinant of the
therpaeutic efficacy of beta-blocker therapy of HF.
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Genetically encoded Ca2þ indicators are important tools that enable the mea-
surement of Ca2þ dynamics in a physiologically relevant context. GCaMP2,
one of the most robust indicators, is a circularly permutated EGFP
(cpEGFP)/M13/Calmodulin (CaM) fusion protein, that has been successfully
used for studying Ca2þ fluxes in vivo in the heart and vasculature of transgenic
mice. Here we describe crystal structures of bright and dim states of GCaMP2
that reveal a sophisticated molecular mechanism for Ca2þ sensing. In the
bright state, CaM stabilizes the fluorophore in an ionized state similar to that
observed in EGFP. Mutational analysis confirmed critical interactions between
the fluorophore and elements of the fused peptides. Solution scattering studies
indicate that the Ca2þ-free form of GCaMP2 is a compact, pre-docked state,
suggesting a molecular basis for the relatively rapid signaling kinetics reported
for this indicator. These studies provide a structural basis for the rational design
of improved Ca2þ-sensitive probes.
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STIM1 and ORAI1, the two limiting components in the CRAC signalling cas-
cade, have been reported to couple tightly upon store-depletion culminating in
CRAC current activation. Based on the homology within the ORAI protein
family, an analogous scenario might be assumed for ORAI2 as well as
ORAI3 channels as both are activated in a similar store- and STIM1-dependent
manner. A combined approach of electrophysiology and confocal Fo¨rster Res-
onance Energy Transfer (FRET) microscopy revealed a general mechanism in
the communication of STIM1 with ORAI proteins that involved the predicted
second coiled-coil motif in STIM1 C-terminus and the conserved putative
coiled-coil domain in the respective ORAI C-terminus. Of the latter, a much
higher coiled-coil probability is predicted for ORAI2 as well as ORAI3 than
for ORAI1, compatible with our observation that a single point coiled-coil
